Rockefeller Capital Management
INAB icon

Rockefeller Capital Management’s IN8bio INAB Stock Holding History

Rockefeller Capital Management’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117 Hold
83
– – ﹤0.01% 4684
2026
Q1 		$123 Hold
83
– – ﹤0.01% 4627
2025
Q4 		$194 Hold
83
– – ﹤0.01% 4593
2025
Q3 		$180 Buy
+83
New +$183 ﹤0.01% 4352

Other funds holding INAB

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Rockefeller Capital Management's INAB Position: Q2 2026 in Review

Rockefeller Capital Management held its IN8bio (INAB) position steady in Q2 2026 at 83 shares worth $117. The position accounts for ﹤0.01% of the portfolio, ranked #4684.

Rockefeller Capital Management first reported a position in INAB in Q3 2025 and has held it in 4 quarters since. The position peaked at $194 in Q4 2025. 21 funds tracked by Wall St. Rank hold INAB as of Q2 2026.

  • Rockefeller Capital Management held 83 shares of IN8bio worth $117 as of Q2 2026.
  • Rockefeller Capital Management left its IN8bio share count unchanged in Q2 2026.
  • IN8bio made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4684 holding.
  • Rockefeller Capital Management first reported a position in IN8bio in Q3 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's IN8bio position peaked at $194 in Q4 2025.
  • 21 funds tracked by Wall St. Rank held IN8bio as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.